EditorUriach

This July, a new issue of the journal Pharmacy, Medicine and History has been published, featuring the winning work, the runner-up, and a work recommended by the jury of the 52nd Uriach Foundation Prize for “History of Medicine”:

• “Psychoanalytic Treatments for Homosexuals in Chile (1952–1957)” by Mr. Marcelo Enríque Valenzuela Cáceres. Winner of the 52nd Uriach Foundation Prize for “History of Medicine.”

• “Surgical Innovation, Private Clinics and Public Charity: Towards a New Model of Care in the City of Valencia” by Mr. Xavier García Ferrandis. Runner-up of the 52nd Uriach Foundation Prize for “History of Medicine.”

• “Oncological ‘War Feats” by Mr. Santos Enrech Francés. Work recommended by the jury of the 52nd Uriach Foundation Prize for “History of Medicine.”

You can read the issue on our website by clicking on the banner on the main page, by visiting the publications section, or through the Issuu digital reader (www.issuu.com), where previous issues of the journal are also available.

The submission period for entries to compete for this year’s 52nd Uriach Foundation Prize for “History of Medicine” (2021) has now closed.

The jury will meet next September to deliberate and vote on the winning work and the runner-up. If the jury deems it appropriate, the winning work, as well as other submitted studies, may be published in the digital journal Pharmacy, Medicine and History, always with the agreement of the authors.

The verdict will be announced in November, and the works that are neither awarded nor selected for publication will be destroyed without the opening of their sealed envelopes, as stipulated in the contest rules.

The Uriach Chair of Nutraceuticals invites you to take part in the conference Functional Foods, Food Supplements, and Nutraceuticals delivered by Dr. Begoña Muguerza.

PROGRAM:

• Presentation of the Uriach Chair of Nutraceuticals

• Relationship between nutrition and health

• Functional foods and their regulation

• Concept of nutraceuticals and food supplements

• Evaluation of functionality

• Case study: collaboration between the Chair and COFT for the evaluation of a nutraceutical’s functionality

Date: Monday, April 26, 2021
Time: 2:30–4:00 p.m.
Place: Online live session via GoToWebinar (only an internet connection and speakers or headphones will be required).

Registration: FREE by clicking HERE (access instructions for the webinar will be sent to the email address provided in the form; please make sure it is entered correctly).

Dr. Begoña Muguerza is Associate Professor in the Department of Biochemistry and Biotechnology at Rovira i Virgili University.

She has taken part in 96 research projects, including a total of 47 publicly funded projects and 49 contracts with companies in the agri-food, nutraceutical, or cosmetics sectors. She has served as project leader or principal investigator in 54 of them.

She is co-author of more than 95 articles in high-impact international scientific journals and of 11 patents. She has supervised 8 doctoral theses, 7 of them with international distinction, and 4 recognized with the Extraordinary Award.

She has also served as Head of the Department of Biochemistry and Biotechnology and Coordinator of the Official Interuniversity Master’s in Nutrition and Metabolism. She currently leads the Nutrigenomics Research Group and is Director of the Uriach Chair of Nutraceuticals.

Dr. Domingo Campillo Valero, neurosurgeon and paleopathologist, passed away last Saturday, April 17, at the age of 93. He served as a member of the jury of the Uriach Foundation Prize for “History of Medicine” on multiple occasions and was the author of the two volumes on paleopathology in our Historical Collection of Health Sciences.

Graduated in Medicine and Surgery in 1951, he specialized in Neurosurgery, Neurology, and Psychiatry, and earned his PhD in Medicine and Surgery in 1974. He was Head of the Department of Surgery and Neurosurgery at Quinta de Salut l’Aliança, in the Central Hospital of Barcelona, and professor of Paleoanthropology and History of Science at the Autonomous University of Barcelona.

As a researcher, he developed his work at the Archaeology Museum of Catalonia, where in 1971 he founded the Laboratory of Paleoanthropology and Paleopathology, becoming its director until 2009. He also served as president of the Catalan Society of Neurosurgery and was a founding member of the Catalan-Balearic Association of Paleopathology.

Dr. Campillo was an international reference in this field of study thanks to his research and teaching, as well as for the innovations he introduced into the discipline.

Metal tin of Fosfatina Falieres, a product that for many years was manufactured and distributed exclusively throughout the country by the Uriach Laboratories.

Fosfatina, originally created by the French company Chassaing, was indicated as a supplement for infant nutrition and, as the advertising of the time stated: “The best food for children. With milk, it makes a delicious and fortifying porridge, essential during weaning and throughout children’s development. Suitable for delicate stomachs.”

This past February 3, by chance, Dr. Joan Uriach Marsal, founder and president of the Uriach Foundation 1838, and Dr. Josep Danon, former director of the institution, met again. It was a very moving encounter that took place right on the street, in front of Dr. Danon’s home.

Together they add up to an impressive 184 years, the same age as the history of our company. Two living examples of the history of our institution, to whom we owe our very existence.

With the publication of this photograph, the Uriach Foundation 1838 wishes to pay a warm and modest tribute to these two figures who have contributed so much to the industrial, academic, and cultural life of our country.

The internship grant awarded annually by the Uriach Chair of Nutraceuticals has recently been granted. This grant is part of the activities carried out by the CUdN within the framework of the Interuniversity Master’s in Nutrition and Metabolism of Rovira i Virgili University (URV) and the University of Barcelona (UB).

The selected student is Marinona Castells Ingla, who will complete her internship in Uriach’s Innovation Department, a business area whose main objective is to provide the company with the most innovative product portfolio on the market and to drive innovation across the company and its subsidiaries in Portugal and Italy.

Josep Pla-Narbona (1928–2020) passed away last Sunday, December 13, in Sant Cugat del Vallès at the age of 92, due to terminal cancer.

Considered one of the greatest Spanish graphic artists in history, he leaves behind an important artistic legacy through his advertising posters, paintings, and engravings.

Among his advertising work, some of his most popular pieces were created for products such as Polil and Nescafé, but he will be especially remembered for his collaborations with the Uriach Laboratories, with whom he worked for over 40 years, producing true works of art for products such as Biodramina, Lipomin, Pacetyn, and Dolmen.

Born in Barcelona in 1928, Pla-Narbona began his artistic training as an apprentice in advertising drawing workshops with artists such as J. Artigas and R. Fábregas at the School of Arts and Crafts of Barcelona, as well as at the advertising agency R.L. Dupuy in Paris.

A renowned engraver and painter, he received the National Design Award in 2004 and the Creu de Sant Jordi in 2019 for being a model in his discipline, opening new paths for future generations, and earning broad international recognition. He received numerous awards, and his works have been exhibited in some of the world’s finest museums, such as the Baltimore Museum of Art, the Muzeum Narodowe in Warsaw, and the Museum of Modern Art in New York.

Alongside his professional work, Pla-Narbona was also a pioneer in professional associations: he was the first president of the graphic designers’ association Grafistas-Agrupación FAD (today known as ADG-FAD), and also the first president of the Spanish group of the Alliance Graphique Internationale.

The Uriach Foundation, which preserves his works created for the Uriach Laboratories, wishes to honor the memory of this great artist.

On Tuesday, October 10, a virtual ceremony was held to recognize 14 individuals responsible for preserving and enriching the heritage collections of the University of Barcelona.

Among them was Dr. Joan Esteva de Sagrera, a trustee of our Foundation, who served as Dean of the Faculty of Pharmacy and Food Sciences for 10 years (2009–2018). Dr. Sagrera, together with Dr. Anna Maria Carmona, Director of the Museum of Catalan Pharmacy, have been primarily responsible for the preservation and expansion of the museum’s historical collection, which holds more than 2,000 objects, including old pharmaceutical specialties and pharmaceutical advertising posters.

The Uriach Foundation devotes part of its activities to the promotion and dissemination of the history of the Health Sciences and has collaborated on several occasions with the Faculty of Pharmacy of this University in organizing exhibitions related to the history of Pharmacy, as well as being a member of the Medical-Pharmaceutical Institute chaired by Dr. Carmona.

We would like to congratulate Dr. Joan Esteva de Sagrera and Dr. Anna Maria Carmona on receiving this award, which clearly reflects the gratitude and recognition of the university community for the work carried out over so many years.

Advertisement from the 1920s for the product JARABE BEBÉ. A product indicated for treating stubborn coughs in adults and whooping cough in children.

Whooping cough, or pertussis, is a highly contagious acute infectious disease of the upper respiratory tract caused by the gram-negative bacterium Bordetella pertussis. It is characterized by tracheobronchial inflammation and typical fits of violent, spasmodic coughing with a sensation of suffocation, ending with a high-pitched inspiratory “whoop.”

Jarabe Bebé was originally produced by the laboratories Pons, Moreno & Co., located in Burjassot (Valencia), but was exclusively distributed by the laboratories “J. Uriach y Cía. Sociedad en Comandita”.